This inventor holds 2 USPTO granted patents. Top assignee: Gundersen Lutheran Medical Foundation, Inc.. Active years: 2001-2002.
Company Filing History:
Years Active: 2001-2002
Title: Innovations of Steven D. Lovrich in Lyme Disease Diagnosis and Prevention
Introduction
Steven D. Lovrich is an accomplished inventor based in La Crosse, Wisconsin. He has made significant contributions to the field of medical research, particularly in the diagnosis and prevention of Lyme disease. With a total of two patents to his name, Lovrich's work focuses on innovative methods that enhance the understanding and treatment of this disease.
Latest Patents
Lovrich's latest patents include compositions and methods utilizing the borreliacidal epitope(s) of Borrelia burgdorferi outer surface protein C (OspC) for the diagnosis and prevention of Lyme disease. One of his notable inventions describes an OspC Dra fragment fusion peptide that is isolated for the prevention, treatment, and early diagnosis of Lyme disease in both humans and animals. This invention also encompasses a screening method for detecting anti-Osp borreliacidal antibody activity, as well as antibodies that react with a protein fragment encoded by a DraI-SmaI DNA fragment of OspC.
Career Highlights
Lovrich is associated with Gundersen Lutheran Medical Foundation, Inc., where he applies his expertise in medical research. His work has been instrumental in advancing the understanding of Lyme disease and developing effective diagnostic tools.
Collaborations
Throughout his career, Lovrich has collaborated with notable colleagues, including Steven M. Callister and Ronald F. Schell. These partnerships have contributed to the success of his research and innovations.
Conclusion
Steven D. Lovrich's contributions to the field of Lyme disease research highlight his dedication to improving medical diagnostics and treatment options. His innovative patents reflect a commitment to advancing healthcare solutions for this prevalent disease.